Molly Stevens Wins Prestigious Royal Pharmaceutical Society Medal
Dr. Molly Stevens, a nanoscience researcher at the Imperial College (UK) Department of Materials, has been awarded the prestigious Royal Pharmaceutical Society of Great Britain’s 2006 Conference Science Medal. The award recognizes for her work in using nanomaterials sciences to support regenerative medicine and tissue transplantation. Dr. Stevens is also the first woman ever to win the award in its 40-year history.
Dr. Molly Stevens
"It was quite a competitive field so I am really pleased to have won the award. I think it is an important milestone for women in the field," Stevens said. The Conference Science Medal is awarded annually to a scientist, in industry or academia, with a proven track record of independent research and whose published work shows outstanding promise.
Dr. Stevens is developing nanomaterials for bio sensing of disease related proteins. Molly and her team of chemists, cell biologists, surgeons, engineers, materials scientists and computer modellers are devising a portable kit which, in the future, could instantly detect the early presence of cancer related enzymes or HIV. She is also working on self assembling nanomaterials to help bones and cartilage quickly repair.
Dr. Stevens is also a regional editor of the Taylor & Francis Group Journal of Experimental Nanoscience.
Dr. Stevens Focus on Exploring
Nanomaterials Science for Health Care
The application of this technology is particularly important in areas where the body currently does not repair itself, for instance, after tumour removal. "The multidisciplinary nature of pharmaceutical science and its focus on healthcare is an important driving force for me in my work. I look forward to highlighting some of the research I have done in regenerative medicine and on new nanomaterials for biosensing when I receive my award," she says.
This is not the first time that Dr. Stevens has been recognized for her outstanding achievements. In the past she beat stiff competition to receive the prestigious Phillip Leverhulme Prize for Engineering. She’s also been named in the internationally acclaimed Technology Review’s TR 100 list of the world’s top young innovators.
Dr. Stevens recently described areas of her research and expertise at a recent conference on Stem Cells and Regenerative Medicine. Highlighted areas of her talk at that event included:
- Range of materials considered for tissue engineering
- Research into cell-material interaction
- Development of new technologies
- Highly tailored biomaterials: Role in guiding cell behaviour and tissue regeneration
- Medical implants
- Use of commonly available clinical bioresorbable polymers
- Use of bioactive materials: Bioglass
- Utilizing self-assembling nanoscale fibres, peptide functionalisation and recombinant DNA technology
- Replication of structure and function of natural tissue
- Importance of production techniques to control material macro and nano structures.